Offre proposée par
Internship: Formulation of novel vaccine delivery platforms (Scientific), Belgium – 2022
Exciting minds with our Internship ProgrammeEducation required: You are regularly enrolled in a Bachelor/Master in: Pharmaceutical Sciences, Bioengineer or a relative field in an Educational Establishment located in Europe.
Language requirement: English or French
You have good verbal and oral communication skills. You are able to work independently.You have a good knowledge of MS Office package.Knowledge of advanced drug delivery methods is a plus.Start date: February 2022
Duration: 6 months
Requisite: The internship must be mandatory & done in the framework of the curriculum, for which an agreement must be signed between GSK, the student and the Educational Establishment.
Remuneration: according to Belgian legal requirements, the internship will not be paid. However, some expenses will be reimbursed.
Application deadline: We recommend you apply as soon as possible, because we accept ongoing applications and we will close the position once we have enough matching candidates
What will you do?On our internship programme you’ll receive tailored on-the-job training from industry experts combined with early responsibility to help you to develop and progress.
Your duties might include:
Development of novel vaccine formulationsSupport to in vitro studiesCharacterization assays using Dynamic light scattering (DLS), SDS page and HPLC.You’ll be excited by the thought of:Building your scientific knowledge in the drug delivery field.Learning how discovery projects are led in our R&D department.Developing your intercultural skills and ability to work with other R&D departmentsWant to solve some of the world’s biggest health challenges?With over 300 years of innovation, we’re a science-led global healthcare company that delivers billions of innovative products each year. Join us and help millions of people do more, feel better, live longer.
GSK Vaccines – Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
For further information, please visit www.gsk.com.
Patient-focused Research and Development (R&D) is the heart of our business. Our R&D department seeks to discover and develop new vaccines, to protect against diseases where vaccines are not yet available and to improve on those vaccines that already exist. Part of our R&D programme targets diseases particularly prevalent in the developing world, including the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria. Research into candidate vaccines for other diseases of the developing world, such as dengue are at an earlier stage of development.
When it comes to developing the vaccines of the future, we’re looking for real experts in their respective fields who are interested in working in the stimulating environment of an international healthcare company.
We emphasise the value of teamwork and we look for people ready to share our values of transparency, respect, integrity and patient focus.
We’re 100% open to all talent
We’re 100% open to all talent – whatever your gender, marital status, religion, age, colour, race, sexual orientation, nationality or disability. We want to recruit the right people for GSK from the widest possible backgrounds, so we can better serve the diversity of our patients and consumers. And also because it’s the right thing to do.